Archive: 01/10/2018

Study: Improvement in glycemic parameters by adding dapagliflozin to metformin in T2D

Researchers used continuous glucose monitoring (CGM) to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes (T2D) and found significant reductions in mean ...

Oct 1, 2018

1

1

Adherence to annual lung cancer screening needs improvement

A study from the Thoracic Oncology Research Group (TORG), Division of Pulmonary Critical Care, Medical University of South Carolina aimed to examine the adherence to annual low-dose computed tomography (LDCT) screening after ...

Oct 1, 2018

Disruption in combination inhaled corticosteroid therapy may lead to increased rate of exacerbations, hospitalizations

Disruption of the refill of patients' regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control and potentially lead to an increased rate of costly exacerbations and hospitalizations.

Oct 1, 2018

Study looks at brain networks involved with free will

Utilizing lesion network mapping, a recently developed technique for analyzing how the brain works, Ryan Darby, MD, assistant professor of Neurology at Vanderbilt, studied free will perception related to movement decisions.

Oct 1, 2018

0

306

Battle for lungs and minds as tobacco control treaty meeting opens

A meeting on a global tobacco control treaty opened in Geneva Monday, with organisers scrambling to keep cigarette companies at bay, even as the industry demanded a seat at the table.

Oct 1, 2018

1

2

Journey to precision cancer treatment takes off with new passports tool

Cancer research and the future of precision cancer treatment will be accelerated by a new tool developed by scientists at the Wellcome Sanger Institute. The novel tool, called Cell Model Passports, acts as a central hub for ...

Oct 1, 2018

Health-related quality of life overlooked in cancer drug studies

A McMaster University-led review and analysis of randomized clinical trials is questioning whether interventions which prolong progression-free survival in cancer patients, improve their health-related quality of life.

Oct 1, 2018

0

12

Irreversible damage to color vision linked to popular erectile dysfunction drug

In a first-of-its-kind study, Mount Sinai researchers have shown that color vision problems caused by retinal damage on a cellular level can result from a high dose of sildenafil citrate, the popular erectile-dysfunction ...

Oct 1, 2018